3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
5
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Genitourinary
1
CNS
1
Conditions
Pancreatic Neoplasms
97
Neoplasms
28
Carcinoma, Non-Small-Cell Lung
27
Neoplasm Metastasis
23
Urinary Bladder Neoplasms
17
Colorectal Neoplasms
17
Sarcoma
15
Lung Neoplasms
14
Biliary Tract Neoplasms
13
Ovarian Neoplasms
12
Lymphoma, Large B-Cell, Diffuse
12
Breast Neoplasms
12
Lymphoma
10
Cholangiocarcinoma
10
Recurrence
9
Hodgkin Disease
8
Carcinoma, Transitional Cell
8
Adenocarcinoma
8
Lymphoma, Non-Hodgkin
7
Triple Negative Breast Neoplasms
6
Non-Muscle Invasive Bladder Neoplasms
6
Lymphoma, Follicular
6
Stomach Neoplasms
5
Small Cell Lung Carcinoma
5
Rectal Neoplasms
5
Gastrointestinal Neoplasms
5
Colonic Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Multiple Myeloma
4
Lymphoma, T-Cell, Peripheral
4
Interventions
Ifosfamide
5
Filgrastim
5
Peripheral Blood Stem Cell Transplantation
4
Paclitaxel
4
Carboplatin
4
Etoposide
2
Cisplatin
2
tremelimumab
1
poly ICLC
1
pegfilgrastim
1
etoposide phosphate
1
durvalumab
1
Temozolomide
1
Radiotherapy
1
Microarray Analysis
1
Lenograstim
1
Immunohistochemistry
1
Gemcitabine
1
ER 30346
1
Dasatinib
1
Blotting, Western
1
Beclomethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Testicular Neoplasms
×
Gemcitabine
×
Clear all
NCT00551122
2013-01-23
GemTIP
University of Southampton
Phase 1/2
Unknown
23 enrolled